Phase 1 Gastrointestinal Neoplasms Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
Colorectal NeoplasmsGastrointestinal Neoplasms
Janssen Research & Development, LLC220 enrolled10 locationsNCT06663319
Recruiting
Phase 1
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
Antineoplastic AgentsGastrointestinal NeoplasmsFecal Microbiota Transplantation (FMT)
Second Affiliated Hospital, School of Medicine, Zhejiang University90 enrolled1 locationNCT07319364
Recruiting
Phase 1Phase 2
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed
Gastrointestinal Neoplasms
GlaxoSmithKline320 enrolled47 locationsNCT06885034
Recruiting
Phase 1
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
Metastatic CancerGastrointestinal NeoplasmsGastrointestinal Diseases+2 more
IDRX, Inc., a wholly owned subsidiary of GSK, LLC278 enrolled30 locationsNCT05489237